Stay updated on BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Sign up to get notified when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.

Latest updates to the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a Locations section with Massachusetts, Minnesota, and Utah, and removed the separate location subsections for these states. Page revision updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.4%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedThe page's revision indicator was updated: added Revision v3.3.2 and removed Revision v3.2.0.SummaryDifference0.1%

- Check50 days agoChange DetectedRemoved the government funding status notice from the page, eliminating a non-critical informational banner. The content about the trial details, eligibility criteria, and results remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedResults information was added to the Study Details page, including the Results First Posted date and posted outcomes. Safety and efficacy data are now available in the study results section.SummaryDifference0.4%

- Check93 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference3%

- Check100 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.